Abstract
The authors regret stating incorrect reference number of the funding sources. The authors re-state the Acknowledgment statement as below by this Corrigendum. The authors would like to apologise for any inconvenience caused. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2015R1A41042399, 2017M3A9E4065333, 2016R1D1A1B03930518). DOI of original article: https://doi.org/10.1016/j.ejphar.2017.12.038
| Original language | English |
|---|---|
| Pages (from-to) | 139 |
| Number of pages | 1 |
| Journal | European Journal of Pharmacology |
| Volume | 830 |
| DOIs |
|
| Publication status | Published - 5 Jul 2018 |
Bibliographical note
Publisher Copyright:© 2017 Elsevier B.V.
Fingerprint
Dive into the research topics of 'Corrigendum to 'secoisolariciresinol diglucoside inhibits adipogenesis through the AMPK pathway’ [European Journal of Pharmacology (2018) 820:235-244](S0014299917308324)(10.1016/j.ejphar.2017.12.038)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver